The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides
Open accessAbstract
Several epidemiological studies indicate that moderate consumption of wine is associated with a lower incidence of Alzheimer's disease. Wine is enriched in antioxidant compounds with potential neuroprotective activities. However, the exact molecular mechanisms involved in the beneficial effects of wine intake on the neurodegenerative process in Alzheimer's disease brain remain to be clearly defined. Here we show that resveratrol (trans-3,4',5-trihydroxystilbene), a naturally occurring polyphenol mainly found in grapes and red wine, markedly lowers the levels of secreted and intracellular amyloid-beta (Abeta) peptides produced from different cell lines. Resveratrol does not inhibit Abeta production, because it has no effect on the Abeta-producing enzymes beta- and gamma-secretases, but promotes instead intracellular degradation of Abeta via a mechanism that involves the proteasome. Indeed, the resveratrol-induced decrease of Abeta could be prevented by several selective proteasome inhibitors and by siRNA-directed silencing of the proteasome subunit beta5. These findings demonstrate a proteasome-dependent anti-amyloidogenic activity of resveratrol and suggest that this natural compound has a therapeutic potential in Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
β-catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,529
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Lindsay, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf074 · Cited by 1,261
Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
Araki, T., Sasaki, Y., & Milbrandt, J. (2004) · Science · doi:10.1126/science.1098014 · Cited by 1,060
Impaired Proteasome Function in Alzheimer's Disease
Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848
Marambaud, P. (2002) · The EMBO Journal · doi:10.1093/emboj/21.8.1948 · Cited by 685
Self-citationResveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons
Parker, J. A., Arango, M., Abderrahmane, S., Lambert, E., Tourette, C., Catoire, H., & Néri, C. (2005) · Nature Genetics · doi:10.1038/ng1534 · Cited by 512
Marambaud, P., Wen, P. H., Dutt, A., Shioi, J., Takashima, A., Siman, R., & Robakis, N. K. (2003) · Cell · doi:10.1016/j.cell.2003.08.008 · Cited by 464
Self-citationJoe, A. K., Liu, H., Suzui, M., Vural, M. E., Xiao, D., & Weinstein, I. B. (2002) · PubMed · Cited by 460
Protective effect of resveratrol on β-amyloid-induced oxidative PC12 cell death
Jang, J. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00062-5 · Cited by 390
Processing of the β‐Amyloid Precursor Protein and Its Regulation in Alzheimer's Disease
Checler, F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65041431.x · Cited by 377
Alcohol Intake and Risk of Dementia
Luchsinger, J. A., Tang, M., Siddiqui, M., Shea, S., & Mayeux, R. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52159.x · Cited by 345
Catalytic Activities of the 20 S Proteasome, a Multicatalytic Proteinase Complex
Orlowski, M., & Wilk, S. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2036 · Cited by 308
Han, Y., Zheng, W., Bastianetto, S., Chabot, J., & Quirion, R. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705688 · Cited by 297
Amount and type of alcohol and risk of dementia: The Copenhagen City Heart Study
Truelsen, T., Thudium, D., & Grønbæk, M. (2002) · Neurology · doi:10.1212/01.wnl.0000031421.50369.e7 · Cited by 280
Amyloid β-Protein Inhibits Ubiquitin-dependent Protein Degradation in Vitro
Gregori, L., Fuchs, C., Figueiredo-Pereira, M. E., Van Nostrand, W. E., & Goldgaber, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19702 · Cited by 233
Defective ubiquitination of cerebral proteins in Alzheimer's disease
L�pez Salon, M., Morelli, L., Casta�o, E. M., Soto, E. F., & Pasquini, J. M. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20001015)62:2<302::aid-jnr15>3.0.co;2-l · Cited by 224
Passer, B., Pellegrini, L., Russo, C., Siegel, R. M., Lenardo, M. J., Schettini, G., Bachmann, M., Tabaton, M., & D'Adamio, L. (2000) · Journal of Alzheimer's Disease · doi:10.3233/jad-2000-23-408 · Cited by 207
Red Wine Ingredient Resveratrol Protects from β-Amyloid Neurotoxicity
Savaskan, E., Olivieri, G., Meier, F., Seifritz, E., Wirz-Justice, A., & Müller-Spahn, F. (2003) · Gerontology · doi:10.1159/000073766 · Cited by 182
A Cell Biological Perspective on Alzheimer's Disease
Annaert, W., & De Strooper, B. (2002) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.18.020402.142302 · Cited by 182
Cao, Z., Fang, J., Xia, C., Shi, X., & Jiang, B.-H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0588 · Cited by 173
Protein quality control in Alzheimer's disease by the ubiquitin proteasome system
de Vrij, F. M. S., Fischer, D. F., VANLEEUWEN, F., & Hol, E. M. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.10.001 · Cited by 155
Elofsson, M., Splittgerber, U., Myung, J., Mohan, R., & Crews, C. M. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80128-8 · Cited by 153
Pozo‐Guisado, E., Lorenzo‐Benayas, M. J., & Fernández‐Salguero, P. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11720 · Cited by 150
Barelli, H., Lebeau, A., Vizzavona, J., Delaère, P., Chevallier, N., Drouot, C., Marambaud, P., Ancolio, K., Buxbaum, J. D., Khorkova, O., et al. (1997) · Molecular Medicine · doi:10.1007/bf03401708 · Cited by 144
Self-citationTargeting Amyloid‐Degrading Enzymes as Therapeutic Strategies in Neurodegeneration
Turner, A. J., Fisk, L., & Nalivaeva, N. N. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.001 · Cited by 91
Schmitz, A., Schneider, A., Kummer, M. P., & Herzog, V. (2003) · Traffic · doi:10.1111/j.1600-0854.2004.00159.x · Cited by 74
Marambaud, P., & Robakis, N. K. R. K. (2004) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2005.00086.x · Cited by 65
Self-citationSIR2 and aging – the exception that proves the rule
Guarente, L. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02339-3 · Cited by 49
Cited by
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
Quideau, S., Deffieux, D., Douat‐Casassus, C., & Pouységu, L. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201000044 · Cited by 2,730
Kim, D., Nguyen, M. D., Dobbin, M. M., Fischer, A., Sananbenesi, F., Rodgers, J. T., Delalle, I., Baur, J. A., Sui, G., Armour, S. M., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601758 · Cited by 1,074
Autophagy and apoptosis dysfunction in neurodegenerative disorders
Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S. R., Jangamreddy, J. R., Mehrpour, M., Christoffersson, J., Chaabane, W., Moghadam, A. R., Kashani, H. H., et al. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.10.004 · Cited by 1,039
Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future
Zhang, Y., Chen, H., Li, R., Sterling, K., & Song, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01484-7 · Cited by 988
Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects
Rahman, M. M., Rahaman, M. S., Islam, M. R., Rahman, F., Mithi, F. M., Alqahtani, T., Almikhlafi, M. A., Alghamdi, S. Q., Alruwaili, A. S., Hossain, M. S., et al. (2021) · Molecules · doi:10.3390/molecules27010233 · Cited by 852
Metadata
- Authors
- Marambaud, P., Zhao, H., & Davies, P.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-11
- Volume
- 280
- Issue
- 45
- Pages
- 37377-37382
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2070815033
- Cited by
- 749
- References
- 31
- FWCI
- 15.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.